Synthego

Acquired

Your Partner in CRISPR & Molecular Diagnostics

Synthego is a biotech company in Redwood City, United States, founded in 2012. It has raised $468.6M across 7 rounds, most recently a $200.0M Series E in February 2022.

Employees
51–200
Founded
2012
Business Model
B2B
Total Funding
$468.6M
Last Round
$200.0M Series EFeb 2022
Rounds
7
Acquisition Date
Jul 2025

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 7 funding rounds and 11 investors for this company. to use credits for reveals, or explore the API.

About

Synthego is a CRISPR solutions company that provides high-quality reagents, engineered cell lines, and GMP manufacturing services to accelerate life science research and therapeutic development. The company's full-stack genome engineering platform vertically integrates proprietary automation, bioinformatics, and molecular biology to support programs from discovery through clinical trials. Synthego serves thousands of academic and commercial researchers worldwide across gene editing, molecular diagnostics, and cell and gene therapy applications.

Funding & Exit History

Data from Indexed.vcUpdated
AcquisitionJul 2025

7 more events

  • Series E20225 investors
  • Series D2020
  • Series C2018

Funding: Seed through Series E. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

22 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Other ×6
  • Backend ×3
  • Marketing & SEO ×3
  • Engineering & DevOps ×2
  • Productivity & Collaboration ×2
  • Analytics ×1
  • +5 more

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

PacBioIPO

Developer and manufacturer of high-accuracy long-read DNA sequencing systems and consumables for ...

USA, United States501–1000Biotech
ConvertibleTotal funding$1.2BFeb 2021
Element Biosciences

Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...

San Diego, United States201–500Biotech
Series ETotal funding$853.3MJun 2026
LifeMine

Therapeutics company working in drug discovery and development using fungi with genomics approach...

Watertown, United States51–200Biotech
Venture RoundTotal funding$816.0MAug 2026
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech
Corporate RoundTotal funding$730.0MDec 2025
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Synthego on Indexed.vc
<a href="https://indexed.vc/companies/synthego"><img src="https://indexed.vc/api/badge/company/synthego" alt="Synthego on Indexed.vc" width="260" height="76" /></a>